atovaquone

Description: Atovaquone (also called atavaquone) is a hydroxynaphthoquinone based antiprotozoal and antimicrobial medication used to treat or prevent for pneumocystis pneumonia, toxoplasmosis, malaria, and babesia. Atovaquone is a chemical compound that belongs to the class of naphthalenes. Atovaquone is a hydroxy-1, 4-naphthoquinone, an analog of ubiquinone, with antipneumocystic activity. Atovaquone is an anti-protozoal mitochondrial electron transport inhibitor; Antimalarial; Antipneumocystic, and has also been used to treat toxoplasmosis. It acts by inhibiting the cytochrome bc(1) complex via interactions with the Rieske iron-sulfur protein and cytochrome b in the ubiquinol oxidation pocket.

References: Am J Trop Med Hyg. 1996 Jan; 54(1):62-6; J Biol Chem. 2003 Aug 15; 278(33):31312-8; Antimicrob Agents Chemother. 2002 May; 46(5): 1163–1173.

Related CAS No: 2070015-14-2 (Atovaquone D4)